MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Remyelination

Home
Remyelination
A pair of hands around a crystal ball that has the year 2026 written inside it.

Multiple Sclerosis Research In 2026

MStranslate
January 5, 2026
Progressive MS, Remyelination, Treatments
2026 is upon us!  As fireworks ring out around the world to usher in the new year, we like to look ahead and think about what new developments we might see in multiple sclerosis research over the coming 12...
Key developments

Multiple Sclerosis in 2025 – Key Developments to Date

MStranslate
May 7, 2025
Cambridge, ECTRIMS, Remyelination, Research
1 Comment
In approximately 3 weeks, we will be celebrating World Multiple Sclerosis Day.  The theme in 2025 is ‘Navigating MS Together’, which perfectly aligns with everything that we stand for at MStranslate.  In...
retinoic acid and calcitriol

Retinoic Acid and Calcitriol May Promote Remyelination

MStranslate
June 25, 2024
Remyelination, Research, Treatments
Research Summary: The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal...
An image of the human brain with nerve cells firing and then a zoomed in image of a nerve with impulses going off in various directions

Clemastine Repairs Damage In Multiple Sclerosis

MStranslate
July 4, 2023
Clinical Trials, Neuroimaging, Remyelination
Research Summary: MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial Remyelination or myelin repair is the next big step in the treatment of multiple sclerosis. ...
remyelination research

Remyelination in Multiple Sclerosis: New Insights

MStranslate
January 16, 2023
Dr Travis Stiles, ECTRIMS, Remyelination, Research
1 Comment
Late in 2022, we published two new videos that provided insights on the topic of remyelination research in multiple sclerosis (MS). The first video was recorded at the European Committee for Treatment and...
Digoxin

Heart Medication Shows Potential to Repair Myelin

MStranslate
August 16, 2022
Remyelination, Research, Treatments
Research Summary: Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis The ability to repair myelin damage...
Novoron Bioscience

Novoron Bioscience: Remyelination Research

MStranslate
May 16, 2022
Dr Travis Stiles, Remyelination, Research
In the past, our co-founder, Brett Drummond, and MStranslate partner, Dr Travis Stiles, have talked broadly about developments in remyelination research around the world.  However, they have never really...
remyelination

Latest Remyelination Research Developments in MS

MStranslate
November 24, 2021
Dr Travis Stiles, ECTRIMS, Remyelination, Research, Videos
In his first feature as an official member of the MStranslate team, Novoron Bioscience CEO, Dr Travis Stiles, recently sat down with our co-founder, Brett Drummond, to discuss the latest developments in...
Anacardic Acid

Anacardic Acid: Potential Myelin Repair Therapy

MStranslate
August 25, 2020
Remyelination, Research
3 Comments
Remyelination is the next ‘big thing’ in the treatment and management of multiple sclerosis.  The ability to repair damaged myelin in people living with multiple sclerosis has the potential to not only...
calorie restriction

Calorie Restriction Promotes Myelin Repair

MStranslate
August 5, 2020
Diet, Lifestyle, Remyelination, Research
Research Summary: Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis Remyelination or myelin repair is the current ‘holy grail’ of multiple...
  1. 1
  2. 2

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.